Drug search by name
Canakinumab Subcutaneous and Dolutegravir
Determining the interaction of Canakinumab Subcutaneous and Dolutegravir and the possibility of their joint administration.
Check result:
Canakinumab Subcutaneous <> Dolutegravir
Relevance: 24.10.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Canakinumab Subcutaneous
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Canakinumab Subcutaneous-Dolutegravir 10 mg
- Canakinumab Subcutaneous-Dolutegravir 25 mg and 50 mg
- Canakinumab Subcutaneous-Dolutegravir and lamivudine
- Canakinumab Subcutaneous-Dolutegravir and rilpivirine
- Canakinumab Subcutaneous-Dolutegravir Sodium
- Canakinumab Subcutaneous-Dolutegravir Sodium And Lamivudine
- Dolutegravir-Canasa
- Dolutegravir-Canasa Pac rectal
- Dolutegravir-Canasa rectal
- Dolutegravir-Cancidas
- Dolutegravir-Candesartan
- Dolutegravir-Candesartan and Hydrochlorothiazide
Doktika World
Interaction with food and lifestyle
Disease interaction